SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer
Clinical trial NCT05826509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05826509
- Sponsor
- Institut Claudius Regaud
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2031-02-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.